5TH2
Cetuximab Fab in complex with L5Q meditope variant
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL12-2 |
Synchrotron site | SSRL |
Beamline | BL12-2 |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2015-02-05 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.0000 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.190, 83.120, 212.560 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 44.770 - 1.840 |
R-factor | 0.1624 |
Rwork | 0.161 |
R-free | 0.18440 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.006 |
RMSD bond angle | 0.873 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (1.10_2155) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 44.770 | 1.890 |
High resolution limit [Å] | 1.840 | 1.840 |
Rmerge | 0.060 | 0.787 |
Number of reflections | 91890 | |
<I/σ(I)> | 15 | |
Completeness [%] | 92.3 | 94.6 |
Redundancy | 3.5 | 3.3 |
CC(1/2) | 0.999 | 0.677 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M citric acid, 0.1 M Na2HPO4, 0.4 M K2HPO4, 1.6 M NaH2PO4 |